Stay updated with breaking news from Malcolm Mccomas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Ben Glickman Pharmaxis will sell its mannitol respiratory business as part of a broader restructuring and pivot to focusing on treating blood-related...
Earlier this month, it took aim at BlackRock, the world’s largest asset manager, accusing it of poor portfolio management and corporate governance failures.
Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) has strengthened its board through the appointment of experienced life sciences investment professional Hashan De Silva...
Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) has appointed experienced senior global pharma executive Dr Simon Green to the Board of Directors as an independent...
Actinogen Medical is a biotech with a potentially "gazillion" dollar opportunity in its Alzheimer's drug